Russia PREVENT (HIV Prevention Partnership in Russian Alcohol Treatment)
HIV Prevention Partnership in Russian Alcohol Treatment
2 other identifiers
interventional
180
1 country
1
Brief Summary
The purpose of this study is to test an HIV prevention intervention in a Russian substance abuse treatment facility using a randomized trial study design.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_1
Started Oct 2004
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2004
CompletedFirst Submitted
Initial submission to the registry
September 9, 2005
CompletedFirst Posted
Study publicly available on registry
September 16, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2005
CompletedJuly 21, 2017
July 1, 2017
September 9, 2005
July 19, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
HIV risk behaviors:
risky alcohol use
risky drug use
risky sex behavior
Secondary Outcomes (2)
RAB score
Addiction Severity Index (ASI)
Interventions
Eligibility Criteria
You may qualify if:
- Age 18-70 years old;
- In-patient at LRCA (i.e., primary diagnosis of alcohol or drug dependence);
- Abstinence from alcohol and other substances of abuse for 4 days;
- Willingness to undergo HIV testing as per standard narcology hospital counseling and testing protocol or known positive HIV serostatus;
- Provision of contact information (e.g., name, home address, telephone number) of two relatives or close friends who can be contacted to share information that may be used to assist with follow-up;
- Stable address within St. Petersburg or districts within 100 kilometers of St. Petersburg; and
- Self-reported unprotected anal or vaginal sex in the last 6 months;
You may not qualify if:
- Not fluent in Russian;
- Severe cognitive impairment (Clinically apparent dementia, active psychosis, or severe paranoid disorder) as judged by a narcology hospital clinician and stated in the records;
- Inability to provide informed consent;
- Suspected or diagnosed pulmonary tuberculosis, not receiving treatment;
- Pending legal charges with potential impending incarceration.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Boston Medical Center
Boston, Massachusetts, 02118, United States
Related Publications (1)
Samet JH, Krupitsky EM, Cheng DM, Raj A, Egorova VY, Levenson S, Meli S, Bridden C, Verbitskaya EV, Kamb ML, Zvartau EE. Mitigating risky sexual behaviors among Russian narcology hospital patients: the PREVENT (Partnership to Reduce the Epidemic Via Engagement in Narcology Treatment) randomized controlled trial. Addiction. 2008 Sep;103(9):1474-83. doi: 10.1111/j.1360-0443.2008.02251.x. Epub 2008 Jul 10.
PMID: 18636998DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Jeffrey H. Samet, MD, MA, MPH
Boston Medical Center
- PRINCIPAL INVESTIGATOR
Evgeny Krupitsky
Leningrad Regional Center of Addictions Institution: Pavlov State Medical University
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, General Internal Medicine
Study Record Dates
First Submitted
September 9, 2005
First Posted
September 16, 2005
Study Start
October 1, 2004
Study Completion
December 1, 2005
Last Updated
July 21, 2017
Record last verified: 2017-07